Trevi Therapeutics Inc (NASDAQ:TRVI)
| 1.83 Delayed Data As of Mar 30 |  +0.05 / +2.78%Today’s Change | 1.43 Today|||52-Week Range 4.68 | -5.18% Year-to-Date |
Latest TRVI News | Press Releases
No recent news for Trevi Therapeutics Inc.
Today’s Trading
| Previous close | 1.80 |
| Today’s open | 1.80 |
| Day’s range | 1.77 - 1.86 |
| Volume | 14,980 |
| Average volume (3 months) | 96,860 |
| Market cap | $106.3M |
Data as of 3:59pm ET, 03/30/2023
Growth & Valuation
| Earnings growth (last year) | +69.60% |
| Earnings growth (this year) | +20.00% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AFMDAffimed NV | -0.02 | -2.22% |
| LIFEaTyr Pharma Inc | -0.01 | -0.47% |
| CLLSCellectis SA | +0.11 | +5.76% |
| EYPTEyePoint Pharmaceuti... | -0.20 | -5.88% |
Data as of 3:59pm ET, 03/30/2023
Financials
| Next reporting date | May 11, 2023 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$29.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
